Fiona Mack, PhD

Fiona Mack is currently Vice President, Head of Bayer CoLab in Cambridge. In this role she is building a new cell and gene therapy incubator to accelerate innovation within the field. Prior to joining Bayer, as Head of JLABS@ TMC, Fiona was responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. She catalyzed and supported the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer, and healthtech sectors. Fiona has held senior leadership positions at Ipsen, Roche and Pfizer supporting external innovation efforts to expand Rare Disease, Neuroscience and Oncology portfolios. Fiona earned her Ph.D. in Cell and Molecular Biology from the University of Pennsylvania and her undergraduate degree in Biology from Cornell University. Her innovative work has been published in high impact journals and she also has several granted patents.

Event: Why haven't we cured cancer? (October 28)